Audit in process? Call the number on your audit letter to get options.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
July 1, 2024 - Samsung Bioepis and Sandoz announced the FDA approval of Pyzchiva (ustekinumab-ttwe), biosimilar to Janssen’s Stelara® (ustekinumab)./p>
Download PDF
Return to publications
